Precision Medicine: Key Updates for Treatment of NSCLC

EP. 1: ADAURA Trial; Early Stage Non–Small Cell Lung Cancer

August 10th 2020

EP. 2: Role of Adjuvant Osimertinib in Early Stage NSCLC

August 10th 2020

EP. 3: TKI Combinations in Metastatic EGFR+ Lung Cancer

August 10th 2020

EP. 4: Chemotherapy-TKI Combinations in Metastatic EGFR+ Lung Cancer

August 10th 2020

EP. 5: EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

August 10th 2020

EP. 6: Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion

August 10th 2020

EP. 7: Trastuzumab Deruxtecan for HER2+ Non–Small Cell Lung Cancer

August 10th 2020

EP. 8: KRAS Testing in Non¬–Small Cell Lung Cancer

August 10th 2020

EP. 9: Trials in ALK-Rearranged Non–Small Cell Lung Cancer

August 10th 2020

EP. 10: Treating ALK-Rearranged Non–Small Cell Lung Cancer

August 10th 2020

EP. 11: Rebiopsy at Progression of ALK-Rearranged NSCLC

August 10th 2020

EP. 12: ROS1-Rearranged Non–Small Cell Lung Cancer

August 10th 2020

EP. 13: RET Fusions in Non–Small Cell Lung Cancer

August 10th 2020

EP. 14: MET Exon 14 Mutations in Non–Small Cell Lung Cancer

August 10th 2020

EP. 15: NTRK Fusions in Non–Small Cell Lung Cancer

August 10th 2020

EP. 16: Optimizing Testing Strategies in Non–Small Cell Lung Cancer

August 10th 2020